ResearcherCharles UniversityActive in the last 2 years
Milan Vošmik
Matched on ORCID iD 0000-0001-6497-7505; OpenAlex author ID A5074283156. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 4
- Resolving lipid isomers up to the double bond position level using reversed-phase chromatography, EAD fragmentation, and high-resolution mass spectrometry: App… Co-author DOI 10.1016/j.aca.2026.345225↗
- Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. Co-author DOI 10.1038/s43856-026-01445-5↗
- Long-term aspirin use influences the probability of distant metastases and operability in patients with pancreatic ductal adenocarcinoma: a single-center retro… First author DOI 10.5603/rpor.104017↗
- Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Clinical CA209-9KH Trial. Co-author DOI 10.1007/s40487-024-00309-z↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michal Holčapek · 2 shared papers, 2026 · strength 0.54
- Aml Mustafa Banni · 2 shared papers, 2024–2025 · strength 0.48
- Paper Long-term aspirin use influences the probability of distant metastases and operability in patients with pancreatic duct… DOI 10.5603/rpor.104017↗
- Paper Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Cl… DOI 10.1007/s40487-024-00309-z↗
- Igor Sirák · 2 shared papers, 2024–2025 · strength 0.48
- Paper Long-term aspirin use influences the probability of distant metastases and operability in patients with pancreatic duct… DOI 10.5603/rpor.104017↗
- Paper Stereotactic Radiotherapy Plus Nivolumab in Patients with Locally Advanced Pancreatic Cancer: Results from Phase 1/2 Cl… DOI 10.1007/s40487-024-00309-z↗
- Bohuslav Melichar · 2 shared papers, 2024–2026 · strength 0.45
- Beatrice Mohelníková-Duchoňová · 2 shared papers, 2024–2026 · strength 0.45
- Evelyn Rampler · 1 shared paper, 2026 · strength 0.30
- Marlene Pühringer · 1 shared paper, 2026 · strength 0.30
- Martin Loveček · 1 shared paper, 2026 · strength 0.24
- Ondřej Peterka · 1 shared paper, 2026 · strength 0.24
- Petr Karásek · 1 shared paper, 2026 · strength 0.24
- Jan Trna · 1 shared paper, 2026 · strength 0.24
- Josef Dvořák · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.